Locations now open in NYC with more to follow across the State NEW YORK CITY, February 22, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19 rapid testing around New York. This program is designed to provide New Yorkers, and those visiting, with inexpensive and rapid COVID-19 testing. NY Forward is a collaboration with The Empire State Development Corporation, The Real Estate Board of New York (REBNY), the […]
Search Results for: log in
360Dx NEW YORK – On Opko’s conference call to discuss its fourth quarter earnings results, subsidiary BioReference Laboratories emphasized the demand it has seen for rapid point-of-care tests for SARS-CoV-2 as the pandemic rages on. BioReference Executive Chairman Jon Cohen said on the call that the laboratory has performed 100,000 rapid SARS-CoV-2 tests to date, adding that […]
ESPN Chiefs quarterback Patrick Mahomes had his barber tested for COVID-19 to ensure a safe trim. Then he turned to a game of Uno for late-night entertainment. Former Lions QB Matthew Stafford spent a week isolated in a hotel, traveled by private plane to Minneapolis and started a game without taking a single practice snap. […]
Billboard Completing the 2020-2021 NFL season in the midst of a pandemic was already a herculean task. But putting on a traditional Super Bowl halftime show inside Raymond James Stadium in Tampa Bay, Florida, as COVID-19 continues to rage across the nation seemed like a bridge too far after a year when live performance and […]
Press Release
OPKO Health’s BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing
26
Jan
Jan
BioReference executes COVID-19 testing program for NBA and NHL for 2020-21 seasons, as well as U.S. Women’s and Men’s National Soccer Teams, Winter X Games and NBA G League ELMWOOD PARK, N.J., January 26, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well […]
05
Jan
Jan
January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21. The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]
Press Release
OPKO Health’s BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide
04
Jan
Jan
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]
Press Release
Buffalo Bills and OPKO Health’s BioReference Laboratories Initiate the First Large Scale, Mandatory COVID-19 Fan Testing Program
31
Dec
Dec
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]
Press Release
Auth0 and BioReference Laboratories Answer Patient Demand for Secure, Direct Access to Test Results
10
Dec
Dec
Leading laboratory testing provider seamlessly handles 25x volume increase in patient portal users during COVID-19 with Auth0 BELLEVUE, Wash., Dec. 10, 2020 (GLOBE NEWSWIRE) — Auth0, the identity platform for application teams, today announced that it is providing BioReference Laboratories, Inc., an OPKO Health company and a leading provider of laboratory testing services in the U.S., with […]
